A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
First things first, this is a story of syngas fermentation, not the definitive story, though it’s pretty definitive on the Jupeng Bio story. For the definitive story of the entire landscape of syngas fermentation, it would have been required to bring back the late Richard Forster of LanzaTech, the late Jim Gaddy of BRI, into […]
By Cynthia Thyfault, CEO, QuantaVision Special to The Digest Many promising ventures face a daunting challenge: translating groundbreaking technology into market success. This challenge isn’t merely a matter of technical prowess but often a strategic one. Much like the generals of today who mastered the art of warfare, tech entrepreneurs must navigate the treacherous terrain […]
A team of researchers partnered with Visolis to develop a hydrogenolysis catalyst that can operate at low-pressures (≤ 5 MPa) and demonstrate conversion of a fermentation-derived C6 intermediate to a high value chemical monomer. The rewards? Risk and cost reduction for bioproduct process commercialization. And, developing a stable and selective catalyst for biomass conversion R&D. […]
By Bob Starkey, LEC Partners (formerly Lee Enterprises Consulting) Special to The Digest In October 2023 the Biden Administration announced a USD $7B investment in clean hydrogen production. This historic program, known as the Regional Clean Hydrogen Hubs (H2Hubs), selected 7 locations across the U.S. to develop clean hydrogen infrastructure. The H2Hub concept is important […]
What are the best pathways to generating and upgrading biochemical intermediates. For example, wet waste to mixed volatile fatty acids in arrested methanogenesis. Or, sugars to butyric acid, or 2,3 butanediol. Tasks include mitigation of scalability roadblocks, measurement of finished fuel properties and quantification of blend limitations, demonstration of life-cycle GHG emissions, and more. What’s […]
How can a public biofoundry develop and demonstrate capabilities that enable commercially-relevant biomanufacturing of a wide range of bioproducts by both new and established industrial hosts? The ABF has operated as a BETO-supported project since 2016. In 2017 the ABF expanded to a $20M/year BETO-consortium. The goal? To enable biorefineries to achieve 50% reductions in […]
In this project, researchers aim to engineer Polyketide synthase for production of commodity and specialty chemicals. PKSs provide the potential to access a massive chemical space of useful small molecules, and produce these from renewable carbon sources. This project is making an array of valuable products including several novel plastic (nylon) monomers with potentially better […]
This week we are reporting many positive shifts in risk, particularly relating to hydrogen, ethanol, DME and sorghum in the US. The new BRISKIs are out from the Daily Digest, they are free and here. https://bit.ly/4dqr58U The risk picture. Although D4 RIN values fell 9.46% with a negative effect on risk for the SAF market in the […]
